An International Journal

Prostaglandins & other Lipid Mediators , invites reports of original research, minireviews, reviews, methods articles in the basic and clinical aspects of all areas of lipid mediator research. Lipid mediators are broadly defined as lipophilic molecules that regulate cell-cell communication events, and include (but not necessarily limited to) eicosanoids, endocannabinoids, lysophospholipids, sphingolipids, phospholipids, fatty acids, ether-linked lipids, PAF and oxidized lipids. The purpose of this journal is to provide a medium for the rapid communication of advances and new knowledge in this rapidly growing field. The editors anticipate receiving manuscripts from scientists in the following areas of lipid mediator research: cell biology, developmental biology, genetics, molecular biology, chemistry, biochemistry, physiology, pharmacology, endocrinology, biology, the medical sciences, and epidemiology. The editors will make every effort to advise Authors of the decision on the submitted manuscript within 3-4 weeks of receipt, provided articles are submitted electronically.

The Journal Prostaglandins was founded in 1972. The Journal of Lipid Mediators and Cell Signalling was incorporated into Prostaglandins at the beginning of 1998 and the name of the journal was changed to Prostaglandins & other Lipid Mediators.

All submissions must be submitted by the online submission system at the following web address:

http://ees.elsevier.com/pro/. In case of problems, please contact the author support at

To contact the editor-in-chief - please send the email to:

Dr. Timothy Hla
Center for Vascular Biology
Department of Physiology
University of Connecticut Health Center
263 Farmington Avenue
Farmington, CT 06030-3501
USA
Phone: 860-679-4128
Fax: 860-679-1201
E-mail: polm@uchc.edu

The automatic submission system will convert author's original files to a PDF file of text and figures. Please follow the instructions at the Elsevier Editorial System.
A cover letter should also be included which states the total number of figures and tables. The types of articles of interest to the journal include, Original Research Papers, Minireviews, Reviews, Commentaries and Methods papers. Authors interested in contributing minireviews, reviews or commentaries should contact the Editor-in-chief with their specific proposals. Notice or announcements of future meetings and scientific courses are also encouraged and should be submitted as far in advance of the event as possible.

Upon receipt of the manuscript at the editorial office, the corresponding author will receive a notification of receipt and manuscript number by email. The paper will be assigned to the appropriate editor, who will prepare the review sometimes with outside expertise. The decision will be transmitted to the editorial office, which will then convey the final decision to the author, by email. Every effort will be made to complete this process in 3-4 weeks.

Previous Publication. If a report by the same author(s) has been previously published in any medium that deals in any respect whatsoever with the same data, in part or in full, as those reported in the manuscript being submitted, reprints of the article or the manuscript, be it a full-length report or an abstract, must be submitted with the manuscripts. The author(s) should inform the Editor of the circumstances, similarities, and differences of the reports. Articles previously published in another language will not be considered.

Animal and Human Studies. It is assumed by the editor that manuscripts emanating from a particular institution are submitted with the approval of the requisite authority for animal use and human studies. The species of non-human animals must be named in the title, abstract, and keywords of the manuscript.

Authorship. Each author must state in the cover letter that he/she has participated actively and sufficiently in the study that is being reported. The inclusion of each author in the authorship list of a report is based only (1) on substantial contributions to (a) concept and design, or analysis and interpretation of data and (b) drafting the manuscript or revising it critically for important intellectual content; and (2) on final approval by each author of the version of the manuscript. Condition 1 (a and b) and 2 must both be met. Others contributing to the work should be recognized separately in an Acknowledgment. In the covering letter that accompanies the submitted manuscript, it must be confirmed that all authors fulfilled both conditions.

GENERAL REQUIREMENTS

Detailed instructions from the Elsevier automatic submission system must be followed to succesfully convert the original source files to a PDF file.

Preparation of Manuscripts. Manuscripts must be typed double-spaced using a standard word processing program, such as MS-Word or WordPerfect. It is preferred that manuscript and figure files be converted into a portable document format (PDF) file in the order described below and submitted to the editorial office by email (polm@uchc.edu). In cases where it is not possible, original files may be submitted with an accompanying letter that describes the list of files.

Title Page. The title of the paper should be centered near the top of the first page with the name(s) and affiliation(s) of the author(s) just below. The title of the paper should be brief; no longer than 100 characters in length, and should capture and communicate the key message of your research to a broader audience. To aid this, abbreviations, unless familiar to a broad audience, should be avoided. In cases of multiple authors and multiple affiliations, utilize symbols to key the affiliations with the authors. The name and complete address to whom all correspondence should be directed (including reprint requests) should be clearly indicated.

Text. The text of the article should include the following: ABSTRACT (approximately 150 words), INTRODUCTION, MATERIALS and METHODS, RESULTS, DISCUSSION, and ACKNOWLEDGMENT/FOOTNOTES. RESULTS and DISCUSSION sections may be combined. The use of subheadings is allowed.

Figures. All figures (photographs, drawings, diagrams, charts) should be clear, easily legible and cited consecutively by Arabic numerals in the text (Figure 1, Figure 2, etc.). All figure legends should be typed on one separate page. Legends should contain sufficient detail to permit figure interpretation without reference to the texts. Units of measure should be indicated in the figures. Figures should be prepared using common graphics programs such as Photoshop, Illustrator, PowerPoint, etc. and saved as either a JPEG, TIFF or PDF format. The resolution of the figures should be high enough for high quality reproduction; for example, 600 dpi for microscopic images. It is preferred that for review purposes, the size of each figure does not exceed 2 Mbytes.

Colour Figures:

If together with your accepted article, you submit usable colour figures, then Elsevier will ensure, at no additional charge, that these figures will appear in colour on the Web (e.g., ScienceDirect and other sites) regardless of whether these illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions [Please note: Because of technical complications that can arise in converting colour figures to "grey scale" (for the printed version should you not opt for colour in print), please submit in addition usable black-and-white files corresponding to all the colour illustrations.]

Authors should note that a request to revert from full colour to colour only in the electronic publication at the stage of typesetting and proof correction, will require separate editorial agreement, with possible re-review if necessary, and may significantly delay publication of your manuscript.

Tables. Tables must be concise, as simple as possible and cited consecutively by Arabic numerals in the text (Table 1, Table 2, etc.). Each table should be titled and typed on a separate sheet. The title of each table should clearly indicate the nature of the contents. Sufficient detail should be included in the table footnote so as to facilitate interpretation.

References. References must adhere to the specifications of the " Uniform Requirements for Manuscripts Submitted to Biomedical Journals " promulgated by the International Committee of Medical Journal Editors.

References are numbered consecutively in the order in which they appear in the text. Citations should be superscript without parentheses; on the line with parentheses is permissible. Each reference must be cited. Referenced articles must have been published in peer-review publications that are generally accessible. Unpublished data, personal communications, papers presented at meetings and symposia, abstracts, and manuscripts " submitted for publication " are not acceptable as references. Information from such sources may be cited, if necessary, in the text with the sources given in parentheses (e.g., unpublished observations). Papers " in press " may be cited, but must include the journal title and year (if known). Books must include the publisher and year of publication (if known.)

References should be listed in numerical order in the Reference Section, immediately following the Acknowledgments section. Journal names should be abbreviated according to the style of the Index Medicus, National Library of Medicine. Examples of format for (1) periodical, (2) book, and (3) chapter in a book are as follows:

(1) List all authors when six or fewer. When more than six, list first three and add “et al.” Nugteren, D.H., Van Dorp, D.A., Bergstrom, S., Hamberg, M., and Samuelsson, b. Absolute Configuration of the Prostaglandins. Nature 212:39. 1966.

(2) Ramwell, P.W., ed., Prostaglandins vol. III. Plenum, London, 1969. P. 65.

(3) Karim, S.M.M. In: Prostaglandins. Peptides, and Amines. (P. Mantegazza and E. W. Horton, eds.) Academic Press, London. 1969, p. 65.

Abbreviations, Symbols and Terminology. Authors should refer to the Council of Biology Editors Style Manual (5th ed., Council of Biology Editors, 1983). Whenever a new or special abbreviation is used, it must be defined in the text or in a footnote the first time it is used. Prostaglandin nomenclature need not be defined. Chemical and biochemical terms and abbreviations should be in accordance with the recommendations of the IUPAC-IUB Combined Commission on Biochemical Nomenclature. Isotope specification should conform to the IUPAC system, with the mass number placed as a superscript preceding the chemical symbol. For spelling, compounding, and word division, authors should follow either Webster's Third International or the Oxford Dictionary.


Trade names of drugs and chemicals may not be mentioned in titles, figures or tables. A trademarked name may be mentioned in parentheses in the first text reference to the drug.

Receptor and channel nomenclature should follow recommendations of the International Union of Pharmacology nomenclature committee, which are regularly published in the journal Pharmacological Reviews.

Copyright: Upon acceptance of an article, authors will be asked to Transfer copyright. This transfer will ensure the widest possible dissemination of information. If material from other copyrighted works is included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has pre-printed forms for use by authors in these cases: contact Elsevier Rights Department, P.O. Box 800, Oxford, OX5 1DX, UK, phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions@elsevier.com. Requests may also be completed online via the Elsevier home page ( http://www.elsevier.com/locate/permissions).

Supplementary material:

Electronic supplementary material is now accepted to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please ensure that data is provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our Corporate Website at http://www.elsevier.com/authors

US National Institutes of Health (NIH) voluntary posting (" Public Access") policy Elsevier facilitates author response to the NIH voluntary posting request (referred to as the NIH "Public Access Policy"; see http://www.nih.gov/about/publicaccess/index.htm) by posting the peer-reviewed author's manuscript directly to PubMed Central on request from the author, 12 months after formal publication. Upon notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at NIHauthorrequest@elsevier.com) that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number to facilitate processing. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will include peer-review comments, for posting 12 months after formal publication. This will ensure that you will have responded fully to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting is prohibited.

Authors in Japan please note: Upon request Elsevier K.K. will provide authors with a list of people who can check and improve the English of their paper (before submission). Please contact our Tokyo office: Elsevier K.K., 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, tel: (+81) 3 5561-5032, fax: (+81) 3-5561-5045.

PDF proofs will be sent by e-mail to the corresponding author. To avoid delay in publication, only necessary changes should be made, and corrections should be returned promptly (i.e. Within 48 hrs of receipt).

Offprints:

The corresponding author, at no cost, will be provided with a pdf offprint.

Author enquiries:

For enquiries relating to the submission of articles (including electronic submission where available) please visit this journal's EES page. You can track accepted articles at http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when an article's status has changed, as well as copyright information, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided after registration of an article for publication.

Disclaimer:

Whilst every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinion or statement appears in this journal, they wish to make it clear that the data and opinions appearing in the articles and advertisements herein are the sole responsibility of the contributor or advertiser concerned. Accordingly, the publishers, the editorial board and editors and their respective employees, officers and agents accept no responsibility or liability whatsoever for the consequences of any inaccurate or misleading data, opinion or statement.